PMDA drug package insert
クイントバック水性懸濁注射用
PMDA Prescription drug · KMバイオロジクス株式会社 · package insert May 13, 2026
Key facts
| Brand names | クイントバック水性懸濁注射用 |
|---|---|
| Nonproprietary names | 沈降精製百日せきジフテリア破傷風不活化ポリオヘモフィルスｂ型混合ワクチン |
| Companies | 製造販売元／KMバイオロジクス株式会社, 販売元／Meiji Seika ファルマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | ワクチン・トキソイド混合製剤 |
| Therapeutic category codes | 876361 |
| YJ codes | 636140FG2027 |
| Approval numbers | 30500AMX00275 |
| Package insert edition | 第3版 |
| Package insert date | May 13, 2026 |
| PMDA document key | 261976_636140FG2027_1 |
| PMDA company code | 261976 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: